Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Depreciation & Amortization (CF) (2022 - 2023)

Historic Depreciation & Amortization (CF) for Therapeutics (LENZ) over the last 2 years, with Q4 2023 value amounting to $4000.0.

  • Therapeutics' Depreciation & Amortization (CF) fell 9941.35% to $4000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $15000.0, marking a year-over-year decrease of 9936.22%. This contributed to the annual value of $58000.0 for FY2024, which is 28666.67% up from last year.
  • Latest data reveals that Therapeutics reported Depreciation & Amortization (CF) of $4000.0 as of Q4 2023, which was down 9941.35% from $4000.0 recorded in Q3 2023.
  • Over the past 5 years, Therapeutics' Depreciation & Amortization (CF) peaked at $682000.0 during Q4 2022, and registered a low of $3000.0 during Q1 2023.